Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease
Clinical trial NCT04392414 · COMPLETED
Trial details
- NCT number
- NCT04392414
- Sponsor
- Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2020-07-10
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.